Clinic of Nephrology and Renal Transplantation, Laiko General Hospital, Medical School of Athens, National and Kapodistrian University, Athens, Greece.
Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Am J Nephrol. 2021;52(7):548-558. doi: 10.1159/000517358. Epub 2021 Jul 26.
Hypertension is the most prominent risk factor in kidney transplant recipients (KTRs). No study so far assessed in parallel the prevalence, control, and phenotypes of blood pressure (BP) or the accuracy of currently recommended office BP diagnostic thresholds in diagnosing elevated ambulatory BP in KTRs.
205 stable KTRs underwent office BP measurements and 24-h ambulatory BP monitoring (ABPM). Hypertension was defined as follows: (1) office BP ≥140/90 mm Hg or use of antihypertensive agents following the current European Society of Cardiology/European Society of Hypertension (ESC/ESH) guidelines, (2) office BP ≥130/80 mm Hg or use of antihypertensive agents following the current American College of Cardiology/American Heart Association (ACC/AHA) guidelines, (3) ABPM ≥130/80 mm Hg or use of antihypertensive agents, and (4) ABPM ≥125/75 mm Hg or use of antihypertensive agents.
Hypertension prevalence by office BP was 88.3% with ESC/ESH and 92.7% with ACC/AHA definitions compared to 94.1 and 98.5% at relevant ABPM thresholds. Control rates among hypertensive patients were 69.6 and 43.7% with office BP compared to 38.3 and 21.3% with ABPM, respectively. Both for prevalence (κ-statistics = 0.52, p < 0.001 and 0.32, and p < 0.001) and control rates (κ-statistics = 0.21, p < 0.001 and 0.22, and p < 0.001, respectively), there was moderate or fair agreement of the 2 techniques. White-coat and masked hypertension were diagnosed in 6.7 and 39.5% of patients at the 140/90 threshold and 5.9 and 31.7% of patients at the 130/80 threshold. An office BP ≥140/90 mm Hg had 35.3% sensitivity and 84.9% specificity for the diagnosis of 24-h BP ≥130/80 mm Hg. An office BP ≥130/80 mm Hg had 59.7% sensitivity and 73.9% specificity for the diagnosis of 24-h BP ≥125/75 mm Hg. Receiver operating curve analyses confirmed this poor diagnostic performance.
At both corresponding thresholds studied, ABPM revealed particularly high hypertension prevalence and poor BP control in KTRs. Misclassification of KTRs by office BP is substantial, due to particularly high rates of masked hypertension. The diagnostic accuracy of office BP for identifying elevated ambulatory BP is poor. These findings call for a wider use of ABPM in KTRs.
高血压是肾移植受者(KTR)最显著的风险因素。迄今为止,尚无研究同时评估血压的患病率、控制率和表型,或评估目前推荐的用于诊断 KTR 动态血压升高的诊室血压诊断阈值的准确性。
205 例稳定的 KTR 接受了诊室血压测量和 24 小时动态血压监测(ABPM)。高血压的定义如下:(1)诊室血压≥140/90mmHg,或根据现行欧洲心脏病学会/欧洲高血压学会(ESC/ESH)指南使用降压药物;(2)诊室血压≥130/80mmHg,或根据现行美国心脏病学会/美国心脏协会(ACC/AHA)指南使用降压药物;(3)ABPM≥130/80mmHg,或使用降压药物;(4)ABPM≥125/75mmHg,或使用降压药物。
根据 ESC/ESH 和 ACC/AHA 定义的诊室血压,高血压患病率分别为 88.3%和 92.7%,而相关 ABPM 阈值下的患病率分别为 94.1%和 98.5%。在高血压患者中,诊室血压的控制率分别为 69.6%和 43.7%,而 ABPM 的控制率分别为 38.3%和 21.3%。两种方法在患病率(κ 统计量=0.52,p<0.001 和 0.32,p<0.001)和控制率(κ 统计量=0.21,p<0.001 和 0.22,p<0.001)方面均有中度或适度的一致性。在 140/90mmHg 阈值下,白大衣性高血压和隐匿性高血压分别在 6.7%和 39.5%的患者中诊断出,在 130/80mmHg 阈值下,分别在 5.9%和 31.7%的患者中诊断出。诊室血压≥140/90mmHg 对诊断 24 小时血压≥130/80mmHg 的敏感度为 35.3%,特异性为 84.9%。诊室血压≥130/80mmHg 对诊断 24 小时血压≥125/75mmHg 的敏感度为 59.7%,特异性为 73.9%。受试者工作特征曲线分析证实了这种较差的诊断性能。
在研究的两个相应阈值下,ABPM 显示 KTR 中高血压的患病率和血压控制率特别高。由于隐匿性高血压的发生率特别高,诊室血压对 KTR 的分类存在大量错误。诊室血压识别动态血压升高的诊断准确性较差。这些发现呼吁在 KTR 中更广泛地使用 ABPM。